293 related articles for article (PubMed ID: 32512716)
21. High incidence of type III secretion system associated virulence factors (exoenzymes) in Pseudomonas aeruginosa isolated from Iranian burn patients.
Khodayary R; Nikokar I; Mobayen MR; Afrasiabi F; Araghian A; Elmi A; Moradzadeh M
BMC Res Notes; 2019 Jan; 12(1):28. PubMed ID: 30646938
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of biofilm production and characterization of genes encoding type III secretion system among Pseudomonas aeruginosa isolated from burn patients.
Jabalameli F; Mirsalehian A; Khoramian B; Aligholi M; Khoramrooz SS; Asadollahi P; Taherikalani M; Emaneini M
Burns; 2012 Dec; 38(8):1192-7. PubMed ID: 22995427
[TBL] [Abstract][Full Text] [Related]
23. Virulent Pseudomonas aeruginosa infection converts antimicrobial amyloids into cytotoxic prions.
Voth S; Gwin M; Francis CM; Balczon R; Frank DW; Pittet JF; Wagener BM; Moser SA; Alexeyev M; Housley N; Audia JP; Piechocki S; Madera K; Simmons A; Crawford M; Stevens T
FASEB J; 2020 Jul; 34(7):9156-9179. PubMed ID: 32413239
[TBL] [Abstract][Full Text] [Related]
24. Similar virulence properties of infection and colonization associated Pseudomonas aeruginosa.
Aditi ; Shariff M; Chhabra SK; Rahman MU
J Med Microbiol; 2017 Oct; 66(10):1489-1498. PubMed ID: 28893354
[TBL] [Abstract][Full Text] [Related]
25. Use of the Galleria mellonella caterpillar as a model host to study the role of the type III secretion system in Pseudomonas aeruginosa pathogenesis.
Miyata S; Casey M; Frank DW; Ausubel FM; Drenkard E
Infect Immun; 2003 May; 71(5):2404-13. PubMed ID: 12704110
[TBL] [Abstract][Full Text] [Related]
26. Activities of Pseudomonas aeruginosa effectors secreted by the Type III secretion system in vitro and during infection.
Lee VT; Smith RS; Tümmler B; Lory S
Infect Immun; 2005 Mar; 73(3):1695-705. PubMed ID: 15731070
[TBL] [Abstract][Full Text] [Related]
27. Elastase Activity From Pseudomonas aeruginosa Respiratory Isolates and ICU Mortality.
Zupetic J; Peñaloza HF; Bain W; Hulver M; Mettus R; Jorth P; Doi Y; Bomberger J; Pilewski J; Nouraie M; Lee JS
Chest; 2021 Nov; 160(5):1624-1633. PubMed ID: 33878342
[TBL] [Abstract][Full Text] [Related]
28. Serotypes and virulence genes of Pseudomonas aeruginosa isolated from mink and its pathogenicity in mink.
Qian Z; Hui P; Han L; Ling-Zhi Y; Bo-Shun Z; Jie Z; Wan-Li G; Nan W; Shi-Jin J; Zhi-Jing X
Microb Pathog; 2020 Feb; 139():103904. PubMed ID: 31801681
[TBL] [Abstract][Full Text] [Related]
29. Contribution of ExsA-regulated factors to corneal infection by cytotoxic and invasive Pseudomonas aeruginosa in a murine scarification model.
Lee EJ; Cowell BA; Evans DJ; Fleiszig SM
Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):3892-8. PubMed ID: 12939306
[TBL] [Abstract][Full Text] [Related]
30. Actin activates Pseudomonas aeruginosa ExoY nucleotidyl cyclase toxin and ExoY-like effector domains from MARTX toxins.
Belyy A; Raoux-Barbot D; Saveanu C; Namane A; Ogryzko V; Worpenberg L; David V; Henriot V; Fellous S; Merrifield C; Assayag E; Ladant D; Renault L; Mechold U
Nat Commun; 2016 Dec; 7():13582. PubMed ID: 27917880
[TBL] [Abstract][Full Text] [Related]
31. Bacterial Nucleotidyl Cyclase Inhibits the Host Innate Immune Response by Suppressing TAK1 Activation.
He C; Zhou Y; Liu F; Liu H; Tan H; Jin S; Wu W; Ge B
Infect Immun; 2017 Sep; 85(9):. PubMed ID: 28652310
[TBL] [Abstract][Full Text] [Related]
32. Pseudomonas aeruginosa infection of airway epithelial cells modulates expression of Kruppel-like factors 2 and 6 via RsmA-mediated regulation of type III exoenzymes S and Y.
O'Grady EP; Mulcahy H; O'Callaghan J; Adams C; O'Gara F
Infect Immun; 2006 Oct; 74(10):5893-902. PubMed ID: 16988269
[TBL] [Abstract][Full Text] [Related]
33. Role of the type III secreted exoenzymes S, T, and Y in systemic spread of Pseudomonas aeruginosa PAO1 in vivo.
Vance RE; Rietsch A; Mekalanos JJ
Infect Immun; 2005 Mar; 73(3):1706-13. PubMed ID: 15731071
[TBL] [Abstract][Full Text] [Related]
34. Virulence genes fliC, toxA and phzS are common among Pseudomonas aeruginosa isolates from diabetic foot infections.
Ertugrul BM; Oryasin E; Lipsky BA; Willke A; Bozdogan B
Infect Dis (Lond); 2018 Apr; 50(4):273-279. PubMed ID: 29078729
[TBL] [Abstract][Full Text] [Related]
35. [Clinical significance of virulence-related genes of type III secretion system of Pseudomonas aeruginosa].
Zhuo C; Wang LX; Xiao SN; Li HY; Qiu GX; Zhong NS
Zhonghua Shao Shang Za Zhi; 2010 Oct; 26(5):354-9. PubMed ID: 21162783
[TBL] [Abstract][Full Text] [Related]
36. The ADP-ribosyltransferase domain of the effector protein ExoS inhibits phagocytosis of Pseudomonas aeruginosa during pneumonia.
Rangel SM; Logan LK; Hauser AR
mBio; 2014 Jun; 5(3):e01080-14. PubMed ID: 24917597
[TBL] [Abstract][Full Text] [Related]
37. Adenylate cyclase activity of Pseudomonas aeruginosa ExoY can mediate bleb-niche formation in epithelial cells and contributes to virulence.
Hritonenko V; Mun JJ; Tam C; Simon NC; Barbieri JT; Evans DJ; Fleiszig SM
Microb Pathog; 2011 Nov; 51(5):305-12. PubMed ID: 21843628
[TBL] [Abstract][Full Text] [Related]
38. Presence of pldA and exoU in mucoid Pseudomonas aeruginosa is associated with high risk of exacerbations in non-cystic fibrosis bronchiectasis patients.
Luo RG; Miao XY; Luo LL; Mao B; Yu FY; Xu JF
Clin Microbiol Infect; 2019 May; 25(5):601-606. PubMed ID: 30036669
[TBL] [Abstract][Full Text] [Related]
39. Virulence gene distribution in clinical, nosocomial and environmental isolates of Pseudomonas aeruginosa.
Bradbury RS; Roddam LF; Merritt A; Reid DW; Champion AC
J Med Microbiol; 2010 Aug; 59(Pt 8):881-890. PubMed ID: 20430902
[TBL] [Abstract][Full Text] [Related]
40. Diversity of virulence genes in multidrug resistant Pseudomonas aeruginosa isolated from burn wound infections.
Haghi F; Zeighami H; Monazami A; Toutouchi F; Nazaralian S; Naderi G
Microb Pathog; 2018 Feb; 115():251-256. PubMed ID: 29273509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
